Chris Mix

SVP, Clinical Development

Chris brings extensive clinical development experience to Dyne, most recently serving as vice president of rare genetic disease clinical development at Agios Pharmaceuticals, where he oversaw development across several hemolytic anemia indications. In his previous role as vice president of clinical development at Sarepta Therapeutics, he focused on advancing candidate therapies for rare neuromuscular disease. Chris received his B.A. in chemistry from Haverford College and his M.D. from the University of Massachusetts Medical School. He completed his residency in internal medicine at Tufts Medical Center, a fellowship in nephrology at the Beth Israel Deaconess Medical Center in Boston and an M.S. in clinical care research at the Tufts School of Biomedical Sciences.

Roles at Dyne Therapeutics

  • SVP, Clinical Development

    Current role


My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Dyne Therapeutics

My pet peeves

My communication style